Case #2: A 60-Year-Old Type 2 Diabetic Woman with MASH and F3 Liver Fibrosis
This Ace the Case activity will review a detailed case discussion on the latest clinical care guidelines and emerging treatments for MASH. Participants will explore novel treatment targets and the most recent clinical data for treating patients with MASH and cardiometabolic comorbidities. Gain practical insights for individualizing patient care plans in your practice. Don’t miss this opportunity to enhance your expertise and improve patient outcomes
Негізгі бет The Intersection of MASH and Cardiometabolic Risk - Case #2
Пікірлер: 1